These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5865599)

  • 1. A congenital inhibitor against factor IX.
    Stocker H
    Thromb Diath Haemorrh; 1965 Nov; 14(3-4):346-60. PubMed ID: 5865599
    [No Abstract]   [Full Text] [Related]  

  • 2. [The problem of female hemophilia. Evolution of ideas and current concepts. Apropos of a case].
    Banda R; Follana R; Moutaffian JJ; Delboy C; Olmer J
    Mars Med; 1972; 109(2):133-40. PubMed ID: 5020467
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemophilia B; two cases of hereditary hemophilia due to a deficiency of a new clotting factor (Christmas factor)].
    CRAMER R; FLUCKIGER P; GASSER C; KOLLER F; LOELIGER A; MATTER M
    Acta Haematol; 1953 Aug; 10(2):64-76. PubMed ID: 13091697
    [No Abstract]   [Full Text] [Related]  

  • 4. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the therapy of congenital hemorrhagic diatheses].
    Heene D; Hörder MH; Schultis K
    Med Welt; 1968 May; 20():1315-7. PubMed ID: 5717761
    [No Abstract]   [Full Text] [Related]  

  • 6. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.
    Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL
    Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital deficiency of plasma thromboplastin component (PTC-factor IX): report of 25 cases from 19 unrelated families.
    Agarwal MB; Mehta BC
    J Assoc Physicians India; 1982 Jan; 30(1):17-9. PubMed ID: 6820363
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On hemophilia C].
    Abezgauz AM; Michurina LS
    Vopr Okhr Materin Det; 1966 Nov; 11(11):58-61. PubMed ID: 5996731
    [No Abstract]   [Full Text] [Related]  

  • 10. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factor IX inhibitor in hemophilia B presented with anaphylactoid symptoms: report of 3 cases].
    Taketani T; Hanada R; Kawaguchi H; Ida K; Yamamoto K
    Rinsho Ketsueki; 1999 Oct; 40(10):1124-6. PubMed ID: 10565232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemophilia B with inhibitor].
    Takahashi I
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):502-5. PubMed ID: 9833555
    [No Abstract]   [Full Text] [Related]  

  • 13. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
    Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood coagulation disorder in a patient with moderate factor XIII and IX deficiency].
    Torsellini A; Zambaldi G; Lombardi V
    Haematologica; 1972; 57(1):57-64. PubMed ID: 4625168
    [No Abstract]   [Full Text] [Related]  

  • 15. [Congenital deficiency of factor IX (Christmas, PTC); hemophilia B].
    HULE V; NESPURKOVA M
    Vnitr Lek; 1955 Mar; 1(3):179-82. PubMed ID: 13247730
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of purified prothrombin in the study of hemophilia and plasma thromboplastin component (PTC) deficiency.
    JOHNSON SA; SEEGERS WH
    J Appl Physiol; 1954 Jan; 6(7):429-36. PubMed ID: 13117776
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma thromboplastin component (PTC) deficiency produced by prolonged administration or prothrombopenic anticoagulants.
    SISE HS; KIMBALL DM; ADAMIS D
    Proc Soc Exp Biol Med; 1955 May; 89(1):81-3. PubMed ID: 14384884
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.
    Mathias M; Khair K; Hann I; Liesner R
    Br J Haematol; 2004 May; 125(3):366-8. PubMed ID: 15086418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple inhibitor screen is more sensitive than a Bethesda assay in monitoring for the development of inhibitors in haemophilia A and B.
    Keeling D; Beavis J; Sukhu K
    Br J Haematol; 2005 Mar; 128(6):885. PubMed ID: 15755295
    [No Abstract]   [Full Text] [Related]  

  • 20. Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex.
    Schimpf K; Schwarz P; Kunschak M
    Thromb Haemost; 1995 Mar; 73(3):553-5. PubMed ID: 7667845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.